198 related articles for article (PubMed ID: 17562781)
21. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
[TBL] [Abstract][Full Text] [Related]
22. Statins effect on smooth muscle cell proliferation.
Bellosta S; Arnaboldi L; Gerosa L; Canavesi M; Parente R; Baetta R; Paoletti R; Corsini A
Semin Vasc Med; 2004 Nov; 4(4):347-56. PubMed ID: 15861311
[TBL] [Abstract][Full Text] [Related]
23. Predicting benefit from statins by C-reactive protein, LDL-cholesterol or absolute cardiovascular risk.
Stewart RA
Future Cardiol; 2009 May; 5(3):231-6. PubMed ID: 19656039
[TBL] [Abstract][Full Text] [Related]
24. The role of statins in endothelial dysfunction in hypertension.
Sarkar K; Sinha AK; Mehta JL
Curr Opin Cardiol; 2006 Jul; 21(4):316-21. PubMed ID: 16755200
[TBL] [Abstract][Full Text] [Related]
25. Role and significance of statins in the treatment of hypertensive patients.
Stepien M; Banach M; Mikhailidis DP; Gluba A; Kjeldsen SE; Rysz J
Curr Med Res Opin; 2009 Aug; 25(8):1995-2005. PubMed ID: 19555312
[TBL] [Abstract][Full Text] [Related]
26. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
27. Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin.
Gazi IF; Daskalopoulou SS; Nair DR; Mikhailidis DP
Curr Med Res Opin; 2007 Sep; 23(9):2183-92. PubMed ID: 17692154
[TBL] [Abstract][Full Text] [Related]
28. Cholesterol-lowering with statins: are they all the same? - Summary of the Expert Symposium at the 53rd Annual Scientific Sessions of the American College of Cardiology.
International Task Force for the Prevention of Coronary Heart Disease
Timely Top Med Cardiovasc Dis; 2004 Sep; 8():E8. PubMed ID: 15543260
[TBL] [Abstract][Full Text] [Related]
29. Statins and direct vascular actions.
Mueck AO; Seeger H
Panminerva Med; 2003 Mar; 45(1):1-6. PubMed ID: 12682615
[TBL] [Abstract][Full Text] [Related]
30. Statins and endothelial dysfunction.
Larose E; Ganz P
Semin Vasc Med; 2004 Nov; 4(4):333-46. PubMed ID: 15861315
[TBL] [Abstract][Full Text] [Related]
31. [Mechanisms of statin nephroprotective actions].
Chmielewski M; Zdrojewski Z; Rutkowski B
Przegl Lek; 2002; 59(7):519-22. PubMed ID: 12516241
[TBL] [Abstract][Full Text] [Related]
32. [About: pleiotropic effects of statins in atherosclerosis].
Ambrosi P
Arch Mal Coeur Vaiss; 2005 Dec; 98(12):1263; author reply 1263-5. PubMed ID: 16435610
[No Abstract] [Full Text] [Related]
33. Vascular health: the emerging appreciation of the endothelium.
Talley JD
J Ark Med Soc; 1997 Feb; 93(9):454-5. PubMed ID: 9046759
[No Abstract] [Full Text] [Related]
34. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
Hou R; Goldberg AC
Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513
[TBL] [Abstract][Full Text] [Related]
35. Blood pressure-lowering effects of statins: who benefits?
Bautista LE
J Hypertens; 2009 Jul; 27(7):1478-84. PubMed ID: 19365283
[TBL] [Abstract][Full Text] [Related]
36. [Non-lipid effects of statins: myth or fact?].
Urbauer E; Joukhadar C
Wien Med Wochenschr; 2003; 153(11-12):244-9. PubMed ID: 12879632
[TBL] [Abstract][Full Text] [Related]
37. Effects of statin therapy on the development and progression of heart failure: mechanisms and clinical trials.
Khush KK; Waters DD
J Card Fail; 2006 Oct; 12(8):664-74. PubMed ID: 17045188
[TBL] [Abstract][Full Text] [Related]
38. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
[TBL] [Abstract][Full Text] [Related]
39. Cross-talk between statins and PPARalpha in cardiovascular diseases: clinical evidence and basic mechanisms.
Paumelle R; Staels B
Trends Cardiovasc Med; 2008 Apr; 18(3):73-8. PubMed ID: 18436144
[TBL] [Abstract][Full Text] [Related]
40. Effects of statins on renal sodium and water handling: acute and short-term effects of atorvastatin on renal haemodynamics, tubular function, vasoactive hormones, blood pressure and pulse rate in healthy, normocholesterolemic humans.
Paulsen L; Holm C; Bech JN; Starklint J; Pedersen EB
Nephrol Dial Transplant; 2008 May; 23(5):1556-61. PubMed ID: 18065809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
